Article citationsMore>>

Terashima, M., Iwasaki, Y., Mizusawa, J., Katayama, H., Nakamura, K., Katai, H., et al. (2019) Randomized Phase III Trial of Gastrectomy with or without Neoadjuvant S-1 plus Cisplatin for Type 4 or Large Type 3 Gastric Cancer, the Short-Term Safety and Surgical Results: Japan Clinical Oncology Group Study (JCOG0501). Gastric Cancer, 22, 1044-1052.
https://doi.org/10.1007/s10120-019-00941-z

has been cited by the following article:

• TITLE: Current Status and Research Progress of Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer

  AUTHORS: Junjian Liu, Tian Wei, Zhiping Xiang, Yinlu Ding

  KEYWORDS: Locally Advanced Gastric Cancer, Adjuvant Chemotherapy, Neoadjuvant Chemotherapy

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.11 No.3, March 30, 2023

  ABSTRACT: Gastric cancer is one of the most common malignant tumours worldwide, with a high degree of malignancy and a poor prognosis. While early gastric cancer can be cured by surgical treatment, locally advanced gastric cancer requires neoadjuvant therapy to shrink the tumour, suppress potential metastases, achieve down-staging, and provide patients with the opportunity for radical surgery to prolong their survival. This article reviews the current status and progress of neoadjuvant chemotherapy for locally advanced gastric cancer.